Financials data is unavailable for this security.
Inc stmt in USDIncome statement in USD
Year on year
Quest Diagnostics Inc grew revenues 22.15% from 7.73bn to 9.44bn while net income improved 66.78% from 858.00m to 1.43bn.
|Net profit margin||20.40%|
|Return on assets||17.45%|
|Return on equity||38.16%|
|Return on investment||20.31%|
Cash flow in USD
Quest Diagnostics Inc did not generate a significant amount of cash. However, the company earned 2.01bn from its operations for a Cash Flow Margin of 21.25%. In addition the company used 772.00m on investing activities and also paid 1.27bn in financing cash flows.
|Cash flow per share||19.77|
|Price/Cash flow per share||7.15|
|Book value per share||48.35|
|Tangible book value per share||-19.00|
Balance sheet in USD
|Total debt/total equity||0.6798|
|Total debt/total capital||0.3999|
Growth rates in USD
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 4.25% and 70.66%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Healthcare Facilities industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
|Div yield(5 year avg)||1.95%|
|Div growth rate (5 year)||8.50%|
|Payout ratio (TTM)||13.76%|
|EPS growth(5 years)||16.56|
|EPS (TTM) vs |
TTM 1 year ago